Gleason Pattern 5 is Frequently Underdiagnosed on Prostate Needle-core Biopsy

被引:16
作者
Al-Hussain, Turki O.
Nagar, Michael S.
Epstein, Jonathan I. [1 ]
机构
[1] Johns Hopkins Univ Hosp, Dept Pathol, Baltimore, MD 21231 USA
关键词
PREDICT PATHOLOGICAL STAGE; CLINICAL STAGE; PARTIN TABLES; CANCER; ANTIGEN; SCORE; CARCINOMA; DISEASE; UPDATE;
D O I
10.1016/j.urology.2011.08.060
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To assess underdiagnosing Gleason pattern 5 on needle biopsy and discuss the potential consequences for patient management. MATERIAL AND METHODS We retrieved 300 consecutive prostate biopsy cases from the consultation files at The Johns Hopkins Hospital (JHH) from 2009-2010 in which we identified Gleason pattern 5. All of these cases were diagnosed by one of the authors and all were sent in as a final diagnosis for which the outside pathologist was not requesting consultation because of difficulty with the diagnosis. The Gleason grades assigned to these cases at our institution were compared with the grade rendered by the submitting pathologists from the outside institution. RESULTS In 146 (48.7%) of the cases, Gleason pattern 5 was not identified by the outside pathologists. Of the 146 cases, the outside Gleason score was <= 7 in 61 (20.3%) and 4 + 4 = 8 in 85 (28.4%). Even when the tumor was diagnosed at JHH as Gleason score 5 + 5 = 10, only 26 (41.3%) were diagnosed as the same by the outside pathologists; Gleason score 9 was graded in 27 (42.8%). CONCLUSION Considering the important prognostic and therapeutic implication of misdiagnosing Gleason pattern 5, efforts should be made by the pathology community to acknowledge this as a problem and improve on individual pathologists' accuracy by diverse medical education programs. In addition, urologists should not hesitate in sending biopsies with high-grade prostate cancer for expert genitourinary pathology second opinions. UROLOGY 79: 178 -181, 2012. (C) 2012 Elsevier Inc.
引用
收藏
页码:178 / 181
页数:4
相关论文
共 16 条
[1]   Interobserver reproducibility of Gleason grading of prostatic carcinoma: General pathologists [J].
Allsbrook, WC ;
Mangold, KA ;
Johnson, MH ;
Lane, RB ;
Lane, CG ;
Epstein, JI .
HUMAN PATHOLOGY, 2001, 32 (01) :81-88
[2]  
[Anonymous], INT J RAD ONCOL BIOL
[3]   Percentage of Gleason pattern 4 and 5 predicts survival after radical prostatectomy [J].
Cheng, Liang ;
Davidson, Darrell D. ;
Lin, Haiqun ;
Koch, Michael O. .
CANCER, 2007, 110 (09) :1967-1972
[4]   The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma [J].
Epstein, JI ;
Allsbrook, WC ;
Amin, MB ;
Egevad, LL ;
Bastacky, S ;
Beltrán, AL ;
Berner, A ;
Billis, A ;
Boccon-Gibod, L ;
Cheng, L ;
Civantos, F ;
Cohen, C ;
Cohen, MB ;
Datta, M ;
Davis, C ;
Delahunt, B ;
Delprado, W ;
Eble, JN ;
Foster, CS ;
Furusato, M ;
Gaudin, PB ;
Grignon, DJ ;
Humphrey, PA ;
Iczkowski, KA ;
Jones, EC ;
Lucia, S ;
McCue, PA ;
Nazeer, T ;
Oliva, E ;
Pan, CC ;
Pizov, G ;
Reuter, V ;
Samaratunga, H ;
Sebo, T ;
Sesterhenn, I ;
Shevchuk, M ;
Srigley, JR ;
Suzigan, S ;
Takahashi, H ;
Tamboli, P ;
Tan, PH ;
Têtu, B ;
Tickoo, S ;
Tomaszewski, JE ;
Troncoso, P ;
Tsuzuki, T ;
True, LD ;
van der Kwast, T ;
Wheeler, TM ;
Wojno, KJ .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (09) :1228-1242
[5]  
Fajardo DA, AJSP IN PRESS
[6]   PREDICTION OF PROGNOSIS FOR PROSTATIC ADENOCARCINOMA BY COMBINED HISTOLOGICAL GRADING AND CLINICAL STAGING [J].
GLEASON, DF ;
MELLINGE.GT .
JOURNAL OF UROLOGY, 1974, 111 (01) :58-64
[7]  
GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125
[8]   Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin tables) based on cases from 2000 to 2005 [J].
Makarov, Danil V. ;
Trock, Bruce J. ;
Humphreys, Elizabeth B. ;
Mangold, Leslie A. ;
Walsh, Patrick C. ;
Epstein, Jonathan I. ;
Partin, Alan W. .
UROLOGY, 2007, 69 (06) :1095-1101
[9]  
Mellinger GT, 1977, CANCER RES, V60, P61
[10]   The prognostic significance of Gleason pattern 5 in prostate cancer patients treated with Pd-103 brachytherapy [J].
Mitsuyama, Hiroki ;
Wallner, Kent ;
Merrick, Gregory ;
Virgin, Jeffrey ;
Orio, Peter ;
Montgomery, Bruce ;
True, Lawrence D. .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (06) :597-600